Key result
Balloon pulmonary angioplasty has emerged as an alternative intervention for non-surgical candidates with chronic thromboembolic pulmonary hypertension to improve functional status.
Balloon pulmonary angioplasty is an emerging endovascular alternative for the management of non-surgical candidates with chronic thromboembolic pulmonary hypertension.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating but potentially reversible complication of chronic pulmonary thromboembolic disease characterized by progressive right heart dysfunction secondary to pulmonary arterial stenosis or occlusion. Balloon pulmonary angioplasty (BPA) has recently emerged as an alternative intervention for non-surgical candidates with CTEPH. Modern reperfusion angioplasty techniques relieve sequela of chronic pulmonary hypertension, ameliorate right ventricular failure, and improve functional status. This article will discuss the diagnosis and treatment of patients with CTEPH and the current state of endovascular management with BPA.
No takes yet. Share an insight, caveat, or question.
Menon et al. (2018) conducted a review in Chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) was evaluated. Balloon pulmonary angioplasty has emerged as an alternative intervention for non-surgical candidates with chronic thromboembolic pulmonary hypertension to improve functional status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: